| Barry Lee Gross, MD | |
|
401 Oyster Point Rd, Suite A, Newport News, VA 23602-6926 | |
| (757) 249-3000 | |
| (757) 269-4424 |
| Full Name | Barry Lee Gross |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 49 Years |
| Location | 401 Oyster Point Rd, Newport News, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235193210 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VG0400X | Obstetrics & Gynecology - Gynecology | 0101029286 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Riverside Regional Medical Center | Newport news, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Riverside Physician Services Inc | 5092608448 | 743 |
News Archive
University of Utah scientists developed a new kind of "molecular condom" to protect women from AIDS in Africa and other impoverished areas. Before sex, women would insert a vaginal gel that turns semisolid in the presence of semen, trapping AIDS virus particles in a microscopic mesh so they can't infect vaginal cells.
An analysis of cervical cancers in Ugandan women has uncovered significant genomic differences between tumors caused by different strains of human papillomavirus (HPV), signifying HPV type may impact cervical cancer characteristics and prognosis.
A team of researchers led by a Boston University Biomedical Engineer has developed a new joint lubricant that could bring longer lasting relief to millions of osteoarthritis sufferers.
A family of microRNAs (miR-200) blocks cancer progression and metastasis by stifling a tumor's ability to weave new blood vessels to support itself, researchers at The University of Texas MD Anderson Cancer Center report today in Nature Communications.
Researchers from UCLA's Jonsson Comprehensive Cancer Center have identified a possible new therapeutic strategy using two types of drug inhibitors at once to treat one of the world's deadliest cancers.
› Verified 3 days ago
| Entity Name | Riverside Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194929026 PECOS PAC ID: 5092608448 Enrollment ID: O20040207000400 |
News Archive
University of Utah scientists developed a new kind of "molecular condom" to protect women from AIDS in Africa and other impoverished areas. Before sex, women would insert a vaginal gel that turns semisolid in the presence of semen, trapping AIDS virus particles in a microscopic mesh so they can't infect vaginal cells.
An analysis of cervical cancers in Ugandan women has uncovered significant genomic differences between tumors caused by different strains of human papillomavirus (HPV), signifying HPV type may impact cervical cancer characteristics and prognosis.
A team of researchers led by a Boston University Biomedical Engineer has developed a new joint lubricant that could bring longer lasting relief to millions of osteoarthritis sufferers.
A family of microRNAs (miR-200) blocks cancer progression and metastasis by stifling a tumor's ability to weave new blood vessels to support itself, researchers at The University of Texas MD Anderson Cancer Center report today in Nature Communications.
Researchers from UCLA's Jonsson Comprehensive Cancer Center have identified a possible new therapeutic strategy using two types of drug inhibitors at once to treat one of the world's deadliest cancers.
› Verified 3 days ago
| Entity Name | Bay Aging |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780656215 PECOS PAC ID: 7315282274 Enrollment ID: O20181220001896 |
News Archive
University of Utah scientists developed a new kind of "molecular condom" to protect women from AIDS in Africa and other impoverished areas. Before sex, women would insert a vaginal gel that turns semisolid in the presence of semen, trapping AIDS virus particles in a microscopic mesh so they can't infect vaginal cells.
An analysis of cervical cancers in Ugandan women has uncovered significant genomic differences between tumors caused by different strains of human papillomavirus (HPV), signifying HPV type may impact cervical cancer characteristics and prognosis.
A team of researchers led by a Boston University Biomedical Engineer has developed a new joint lubricant that could bring longer lasting relief to millions of osteoarthritis sufferers.
A family of microRNAs (miR-200) blocks cancer progression and metastasis by stifling a tumor's ability to weave new blood vessels to support itself, researchers at The University of Texas MD Anderson Cancer Center report today in Nature Communications.
Researchers from UCLA's Jonsson Comprehensive Cancer Center have identified a possible new therapeutic strategy using two types of drug inhibitors at once to treat one of the world's deadliest cancers.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Barry Lee Gross, MD 856 J Clyde Morris Blvd, Suite A, Newport News, VA 23601-1318 Ph: () - | Barry Lee Gross, MD 401 Oyster Point Rd, Suite A, Newport News, VA 23602-6926 Ph: (757) 249-3000 |
News Archive
University of Utah scientists developed a new kind of "molecular condom" to protect women from AIDS in Africa and other impoverished areas. Before sex, women would insert a vaginal gel that turns semisolid in the presence of semen, trapping AIDS virus particles in a microscopic mesh so they can't infect vaginal cells.
An analysis of cervical cancers in Ugandan women has uncovered significant genomic differences between tumors caused by different strains of human papillomavirus (HPV), signifying HPV type may impact cervical cancer characteristics and prognosis.
A team of researchers led by a Boston University Biomedical Engineer has developed a new joint lubricant that could bring longer lasting relief to millions of osteoarthritis sufferers.
A family of microRNAs (miR-200) blocks cancer progression and metastasis by stifling a tumor's ability to weave new blood vessels to support itself, researchers at The University of Texas MD Anderson Cancer Center report today in Nature Communications.
Researchers from UCLA's Jonsson Comprehensive Cancer Center have identified a possible new therapeutic strategy using two types of drug inhibitors at once to treat one of the world's deadliest cancers.
› Verified 3 days ago
Mark Wayne Austin, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 10510 Jefferson Ave, Suite D, Newport News, VA 23601 Phone: 757-594-4720 Fax: 757-594-4735 | |
Kevin Michael Mahoney, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 10510 Jefferson Ave, Ste D, Newport News, VA 23601 Phone: 757-594-4720 | |
Abby Ford Anderson, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 12706 Mcmanus Blvd, Newport News, VA 23602 Phone: 757-874-2229 Fax: 757-874-7525 | |
Dr. Rachel Carroll-bennett, MD/MPH Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 10510 Jefferson Ave Ste D, Newport News, VA 23601 Phone: 757-594-4720 Fax: 757-594-4735 | |
Kathy Edwina O'connell, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 11842 Rock Landing Dr Ste 115, Newport News, VA 23606 Phone: 757-505-9905 Fax: 757-595-5377 | |
Lisa Ann Casanova, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 401 Oyster Point Rd, Suite A, Newport News, VA 23602 Phone: 757-249-3000 Fax: 757-269-4424 | |
Douglas Thom, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 12706 Mcmanus Blvd, Newport News, VA 23602 Phone: 757-874-2229 Fax: 757-874-7525 |